Darren Edward Richard
Chercheur universitaire
Axe Endocrinologie et néphrologie
Publications
Voir tout-
article Larivière R, Ung RV, Picard S, Richard DE, Mac-Way F, Agharazii M
Antihypertensive treatment with hydrochlorothiazide-hydralazine combination aggravates medial vascular calcification in CKD rats with mineral bone disorder
Front Cardiovasc Med 10 2023.
-
article Laporte SA, Servant G, Richard DE, Escher E, Guillemette G, Leduc R
The tyrosine within the NPXnY motif of the human angiotensin II type 1 receptor is involved in mediating signal transduction but is not essential for internalization
Mol Pharmacol 49 (1), 1996.
-
article Goyette MA, Elkholi IE, Apcher C, Kuasne H, Rothlin CV, Muller WJ, Richard DE, Park M, Gratton JP, Côté JF
Targeting Axl favors an antitumorigenic microenvironment that enhances immunotherapy responses by decreasing Hif-1α levels
Proc Natl Acad Sci U S A 118 (29), 2021.
Projets
- Novel Interactions and Functions for Hypoxia-Inducible Factor-1 (HIF-1) during Vascular Responses, du 2016-04-01 au 2027-04-30
- Le polymorphisme génétique du système HLA : une occasion de personnaliser l’immunosuppression et de mieux comprendre la biologie de la réponse immunitaire, du 2024-07-01 au 2027-07-01
- Hydrochlorothiazide and accelerated CKD-related vascular calcification, du 2023-07-01 au 2025-06-30